Bladder cancer, Transitional cell cancer
Results
Phase 3
This study looked at the possibility of doing a larger trial to compare different ways of treating high risk bladder cancer. High risk bladder cancer is more likely to:
come back after treatment or
spread further
The trial was for people whose cancer hadn’t grown into the muscle wall of the bladder. This is called non muscle invasive bladder cancer.
It was open for people to join between 2016 and 2018. The team published the results in 2020.
Recruitment start: 14 October 2016
Recruitment end: 31 March 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor James Catto
Clinical Trials Research Unit (CTRU)
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield
University of Leeds
Yorkshire Cancer Research - YCR
Last reviewed: 21 September 2022
CRUK internal database number: 14414
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
